Cargando…
Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours()()
While radiolabelled antibodies have found great utility as PET and SPECT imaging agents in oncological investigations, a notable shortcoming of these agents is their propensity to accumulate non-specifically within tumour tissue. The degree of this non-specific contribution to overall tumour uptake...
Autores principales: | Knight, James C., Mosley, Michael J., Kersemans, Veerle, Dias, Gemma M., Allen, P. Danny, Smart, Sean, Cornelissen, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599172/ https://www.ncbi.nlm.nih.gov/pubmed/30825614 http://dx.doi.org/10.1016/j.nucmedbio.2019.01.010 |
Ejemplares similares
-
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
por: Torres, Julia Baguña, et al.
Publicado: (2017) -
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
por: Elvina Xavier, Mary-Ann, et al.
Publicado: (2019) -
Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling
por: Knight, James C., et al.
Publicado: (2020) -
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
por: Torres, Julia Baguña, et al.
Publicado: (2020) -
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
por: Kersemans, Veerle, et al.
Publicado: (2010)